The limitations of this research are also phenotypic variability and the influence of unmeasured genetic or environmental modifiers, which remain significant research gaps, as factors beyond SMN2 copy number contribute to clinical heterogeneity in SMA. Here, SMN2 is linked to proximal spinal muscular atrophy.